Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Medicine > 2025 Vol. 3 > No. 3 > 100140
Next Article Previous Article
NEWS & BUZZ   Open Access     Cite

From sleepless nights to restored days: How AD109 is giving obstructive sleep apnea patients their lives back

  • 1.

    The Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu 610041, China

  • 2.

    Respiratory and Critical Care Department, The First Hospital of China Medical University, Shenyang 110001, China

  • 3.

    School of Pharmacy, Queen’s University Belfast, BT7 1NN, UK

More Information
The Innovation Medicine  3(3),  https://doi.org/10.59717/j.xinn-med.2025.100140  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Benjafield A.V., Ayas N.T., Eastwood P.R., et al. (2019). Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis. Lancet Respir. Med. 7:687−698. DOI:10.1016/S2213-2600(19)30198-5

    View in Article CrossRef Google Scholar

    [2] Gleeson M. and McNicholas W.T. (2022). Bidirectional relationships of comorbidity with obstructive sleep apnoea. Eur. Respir. Rev. 31:210256. DOI:10.1183/16000617.0256-2021

    View in Article CrossRef Google Scholar

    [3] Toh S.T. (2023). Pharmacotherapy for obstructive sleep apnea: Reality or Pipe Dream. Sleep Med. Rev. 70:101817. DOI:10.1016/j.smrv.2023.101817

    View in Article CrossRef Google Scholar

    [4] Martinez-Garcia M.A., Campos-Rodriguez F., Barbé F., et al. (2019). Precision medicine in obstructive sleep apnoea. Lancet Respir. Med. 7:456−464. DOI:10.1016/S2213-2600(19)30044-X

    View in Article CrossRef Google Scholar

    [5] Schweitzer P.K., Taranto-Montemurro L., Ojile J.M., et al. (2023). The combination of aroxybutynin and atomoxetine in the treatment of obstructive sleep apnea (MARIPOSA): A randomized controlled trial. Am. J. Respir. Crit. Care Med. 208:1316−1327. DOI:10.1164/rccm.202306-1036OC

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Mo C., Zhao C. and Li W. (2025). From sleepless nights to restored days: How AD109 is giving obstructive sleep apnea patients their lives back. The Innovation Medicine 3:100140. https://doi.org/10.59717/j.xinn-med.2025.100140
    Mo C., Zhao C. and Li W. (2025). From sleepless nights to restored days: How AD109 is giving obstructive sleep apnea patients their lives back. The Innovation Medicine 3:100140. https://doi.org/10.59717/j.xinn-med.2025.100140

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(5021) PDF downloads(5904)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.